• CU Cancer Center study may explain failure of retinoic acid trials against breast cancer

    “What has been missing in clinical trials may just be the timing of the treatments,” says first author Lynsey Fettig.

  • Dr. Lieu to lead committee for investigator-initiated clinical trials

    A University of Colorado Cancer Center investigator has been recognized for leading, educating and supporting…

  • Dinner in White to return for the seventh year

    The University of Colorado Cancer Center is thrilled to announce that the 7th annual Dinner…

  • Thomas Flaig, MD, named chair of NCCN bladder cancer panel

    CU Cancer Center’s Thomas Flaig, MD, has been named chair of the NCCN Clinical Practice Guidelines in Oncology Panel for Bladder Cancer.

  • NEJM case reports show promise of cancer immunotherapy to treat rare lymphoma

    Three case reports published in the New England Journal of Medicine demonstrate the promise of cancer immunotherapy in gray zone lymphoma, potentially paving the way for clinical trials utilizing this strategy in this and related conditions.

Patient Care

“Nothing more I can ask for” – Personalized medicine ensures mom will see her kids grow up

For Sarah McRorie, the time after the birth of her daughter Sloane brought hugs, kisses, new challenges…

Read the rest of this entry

colon cancer cu cancer center

Research

CU Cancer Center study may explain failure of retinoic acid trials against breast cancer

“What has been missing in clinical trials may just be the timing of the treatments,” says first author Lynsey Fettig.

Read the rest of this entry

Meet the Experts

A CONVERSATION WITH ROBERT GARCEA, MD

Cervical cancer is directly related to prior infection with human papillomavirus (HPV). Primarily due to PAP…

Read the rest of this entry